Bio-Techne (TECH) Debt to Equity (2014 - 2026)

Bio-Techne's Debt to Equity history runs 13 years deep, the most recent figure standing at $0.1 for Q1 2026.

• In Q1 2026, Debt to Equity fell 41.35% year-over-year to $0.1; the TTM figure through Mar 2026 stood at $0.1 (down 41.35% YoY), while the FY2025 annual figure was $0.18, up 16.95% from the prior year.
• Debt to Equity was $0.1 for Q1 2026 at Bio-Techne, down from $0.13 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.23 in Q4 2023 to a low of $0.1 in Q1 2026.
• Historically, Debt to Equity has averaged $0.16 across 5 years, with a median of $0.15 in 2024.
• The sharpest annual moves came in 2023 and 2026: Debt to Equity surged 107.97% in 2023, then plunged 41.35% in 2026.
• A 5-year view of Debt to Equity shows it stood at $0.11 in 2022, then soared by 107.97% to $0.23 in 2023, then tumbled by 36.6% to $0.14 in 2024, then slipped by 10.42% to $0.13 in 2025, then dropped by 25.82% to $0.1 in 2026.
• The last three Debt to Equity figures came in at $0.1 (Q1 2026), $0.13 (Q4 2025), and $0.15 (Q3 2025), per Business Quant data.